Tuttle Capital Management’s Translational Development Acquisition Corp Units TDACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-25,000
Closed -$254K 75
2025
Q1
$254K Hold
25,000
1.11% 46
2024
Q4
$251K Buy
+25,000
New +$250K 1.29% 48

Other funds holding TDACU

Tuttle Capital Management's TDACU Position: Q2 2025 in Review

Tuttle Capital Management sold out of Translational Development Acquisition Corp Units (TDACU) in Q2 2025, closing a stake of 25,000 shares — an estimated $254K sold.

Tuttle Capital Management first reported a position in TDACU in Q4 2024 and held it in 2 quarters. The position peaked at $254K in Q1 2025. 9 funds tracked by Wall St. Rank hold TDACU as of Q2 2025.

  • Tuttle Capital Management reported no remaining Translational Development Acquisition Corp Units position as of Q2 2025 after selling out during the quarter.
  • Tuttle Capital Management sold 25,000 Translational Development Acquisition Corp Units shares in Q2 2025, an estimated $254K.
  • Tuttle Capital Management first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and held it in 2 quarters.
  • Tuttle Capital Management's Translational Development Acquisition Corp Units position peaked at $254K in Q1 2025.
  • 9 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q2 2025.

Based on Tuttle Capital Management's 13F filing for Q2 2025, filed 28 Jul 2025.